Moderna Jumps 7% While Melanoma Vaccine Data Looms; Bristol Myers Squibb Rises 5%, Pfizer Advances 2%
Moderna shares are surging ahead of a closely watched cancer data presentation in Madrid, but the company’s razor-thin…
Browsing Category